"10.1371_journal.pone.0112568","plos one","2014-11-13T00:00:00Z","Babs E Verstrepen; Herman Oostermeijer; Zahra Fagrouch; Melanie van Heteren; Henk Niphuis; Tom Haaksma; Ivanela Kondova; Willy M Bogers; Marina de Filette; Niek Sanders; Linda Stertman; Sofia Magnusson; Orsolya Lőrincz; Julianna Lisziewicz; Luisa Barzon; Giorgio Palù; Michael S Diamond; Stefan Chabierski; Sebastian Ulbert; Ernst J Verschoor","Department of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands; Animal Science Department, Division of Pathology and Microbiology, BPRC Rijswijk, The Netherlands; Laboratory of Gene Therapy, Faculty of Veterinary Sciences, Ghent University, Merelbeke, Belgium; Novavax AB, Uppsala, Sweden; eMMUNITY, Inc., Budapest, Hungary; Department of Molecular Medicine, University of Padova, Padova, Italy; Departments of Medicine, Molecular Microbiology and Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany","Conceived and designed the experiments: BEV EJV. Performed the experiments: BEV HO ZF MvH HN TH IK WMB MdeF SC. Analyzed the data: BEV EJV. Contributed reagents/materials/analysis tools: MdeF NS LS SM OL JL LB GP MSD. Contributed to the writing of the manuscript: BEV NS SM JL LB MSD SU EJV.","The authors have read the journals policy and have the following conflicts: SEM and LS are employees of Novavax AB and minority shareholders of Novavax Inc. JL and OL are shareholders of eMMUNITY Inc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.","2014","11","Babs E Verstrepen","BEV",20,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
